Novo Nordisk
Type
investor
Founded
1923
Funding Rounds
1
Portfolio companies
1
About Novo Nordisk
Novo Nordisk is a global healthcare company specializing in diabetes care, obesity, haemophilia, growth disorders and other chronic diseases. The company develops, manufactures and markets pharmaceutical products and devices, and invests heavily in R&D to advance therapies for metabolic and chronic conditions, partnering with research organisations and commercial channels globally to distribute treatments and support patient access.
Novo Nordisk investments captured (1)
| Company Name | Stage | Total Deal Amount | Date |
|---|---|---|---|
| Unknown | undisclosed | Jun 23, 2026 |